COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Grant Status Currently Funded
Division Division of Cancer Control and Population Sciences
Program Epidemiology and Genomics Research Program (EGRP)
Branch Clinical and Translational Epidemiology Branch
PI Name Organization Name Project Title
(Click for Abstract, Pubs, etc.)
Grant Number Initiative
(Click for Funding Announcement)
Awarded Dollars Fiscal Year Abstract Page URL Funding Announcement URL
Afshar-Kharghan, Vahid University of TX MD Anderson Can Ctr Genetics of Graft-Versus-Host Disease 5R01CA231141-02 PA16-160 506458 2019
Anderson, Garnet L. Fred Hutchinson Cancer Research Center Life and Longevity After Cancer (LILAC): the Women's Health Initiative Cancer Survivor Cohort 2U01CA173642-06A1 PAR17-233 1584592 2019
Badve, Sunil S. Indiana Univ-Purdue Univ at Indianapolis (PQC3) Ethnicity-Determined Immune Response and Dcis Outcome 5R01CA194600-05 CA13-020 479117 2019
Bandera, Elisa V Rbhs Cancer Institute of New Jersey Obesity, Related Comorbidities, and Breast Cancer Outcomes in African Americans 5R01CA185623-05 PA11-260 1038141 2018
Baron, John Anthony Univ of North Carolina Chapel Hill The Immune Contexture of Colorectal Adenomas and Serrated Polyps 5R01CA226086-02 PA18-484 625529 2020
Belury, Martha A Ohio State University Dietary Fats, Mitochondrial Function and Muscle Health in Cancer Patients 5R21CA209566-03 PA16-036 107055 2020
Berger, Michael F. Sloan-Kettering Inst Can Research (PQ3) Integrative Biomarkers of Cancer Progression and Therapeutic Response From Germline and Somatic Clinical Sequencing 5R01CA227534-02 CA18-019 712004 2020
Berwick, Marianne University of New Mexico Health Scis Ctr Integration of Clinical and Molecular Biomarkers for Melanoma Survival 5P01CA206980-04 PAR15-023 536127 2020
Beyer, Kirsten M M Medical College of Wisconsin Racism, Residential Racial Segregation, and Breast Cancer Survival Disparities Among Black, Hispanic and Non-Hispanic White Women 5R01CA214805-04 PA13-292 475937 2020
Bhatia, Smita University of Alabama at Birmingham Bmt Survivor Study-2 (Bmtss-2) 5U01CA213140-02 PAR17-233 1354939 2020
Buring, Julie E. Brigham and Women's Hospital Women's Health Study: Infrastructure Support for Cohort Follow-Up 2U01CA182913-06 PAR17-233 715304 2019
Burridge, Paul W. Northwestern University at Chicago Genomic Prediction of Doxorubicin-Induced Cardiotoxicity 5R01CA220002-02 CA17-017 328880 2019
Buys, Saundra S University of Utah Leveraging an Electronic Medical Record Infrastructure to Identify Primary Care Patients Eligible for Genetic Testing for Hereditary Cancer and Evaluate Novel Cancer Genetics Service Delivery Models 5U01CA232826-02 CA17-041 1025425 2019
Caan, Bette J Kaiser Foundation Research Institute Cancer and Body Composition Webinar Series 1R13CA243572-01 PA18-648 19913 2019
Cai, Tianxi Harvard School of Public Health Semi-Supervised Algorithms for Risk Assessment with Noisy Ehr Data 5R21CA242940-02 PAR15-334 177510 2020
Cerhan, James R Mayo Clinic Rochester The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study 3U01CA195568-05S2 PAR14-160 486178 2020
Cerhan, James R Mayo Clinic Rochester The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study 5U01CA195568-05 PAR14-160 2177529 2019
Cheng, Chao Baylor College of Medicine Computational Identification of New Candidate Drugs for Lung Cancer Treatment 5R21CA227996-02 PA16-175 173765 2020
Chow, Eric Jessen Fred Hutchinson Cancer Research Center Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy 5R01CA211996-04 PA13-302 685084 2020
Christensen, Brock Clarke Dartmouth College (PQ3) Immune Epigenetic Biomarkers of Bladder Cancer Outcomes 5R01CA216265-03 CA15-008 593972 2019
Christiani, David C Harvard School of Public Health The Boston Lung Cancer Survival Cohort 5U01CA209414-04 PAR15-104 1237929 2020
Cook, Linda S University of New Mexico Health Scis Ctr A Population Based Study of Ketorolac and Ovarian Cancer Survival 1R01CA236789-01A1 PA19-056 392750 2020
Cote, Michele L Wayne State University Molecular Classification of High Grade Endometrial Cancers: Extending Tcga Findings to a Diverse Population 5R01CA200864-05 PA13-302 336481 2020
Doherty, Jennifer Anne University of Utah Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: an Integrative Approach 1R01CA243188-01A1 PA19-056 1371104 2020
Friedman, Debra L Vanderbilt University Medical Center Research Into Visual Endpoints and Rb Health Outcomes After Treatment: the Riverboat Consortium 5R01CA225005-02 PA16-160 658729 2019
Fuchs, Charles S Yale University Impact of Celecoxib and Inflammation on Survival in Stage Iii Colon Cancer 5R01CA169141-07 PA11-260 410019 2018
Fuchs, Charles S Yale University Dietary and Lifestyle Determinants of Colon Cancer Recurrence and Survival 5R01CA118553-10 PA13-302 428382 2019
Furberg-Barnes, Anna Helena Sloan-Kettering Inst Can Research Body Composition and the Obesity Paradox in Clear Cell Renal Cell Carcinoma 1R01CA233885-01A1 PA18-484 653156 2019
Gentles, Andrew J Stanford University The Prognostic Landscape of Gender and Ethnicity-Specific Immune Influences on Cancer Outcomes 5R21CA238971-02 CA18-020 204233 2020
Gomez, Scarlett L University of California, San Francisco Insights From Asian Populations Into Disparities in Breast Cancer Prognosis and Outcomes 1R01CA241125-01A1 PA19-056 1145972 2020
Gong, Zhihong Roswell Park Cancer Institute Corp Long Noncoding Rna Regulations in Breast Cancer Among African-American Women 1R01CA246688-01A1 PAR18-869 392168 2020
Goode, Ellen L. Mayo Clinic Rochester Epidemiology and Genomics of Ovarian Clear Cell Carcinoma 5R21CA222867-02 PA16-175 167725 2019
Gramatges, Maria Monica Baylor College of Medicine (Pqb-1) Telomere Maintenance Defects and Thyroid Second Cancer in Childhood Cancer Survivors 5R01CA194473-05 CA13-018 217523 2019
Hines, Robert Brooks University of Central Florida Prevention and Treatment of Oxaliplatin-Induced Peripheral Neuropathy 1R03CA241788-01A1 PAR18-021 149000 2020
Hudson, Melissa M St. Jude Children's Research Hospital The St. Jude Lifetime Cohort 2U01CA195547-06 PAR17-233 1208445 2020
Hundley, William Gregory Wake Forest University Health Sciences Understanding and Predicting Fatigue, Cv Decline & Events After Breast CA Treatment 5R01CA199167-04 PA13-302 617373 2019
Johnson, Caroline Helen Yale University Understanding Sex Differences in Colon Cancer Metabolism 5R21CA223686-02 PA16-175 212030 2019
Kantoff, Philip W Sloan-Kettering Inst Can Research The Impact of DNA Damage Repair Abnormalities in Prostate Cancer 1P01CA228696-01A1 PAR18-290 1929187 2019
Kantor, Elizabeth David Sloan-Kettering Inst Can Research Obesity, Chemotherapy Dosing, and Breast Cancer Outcomes 5R37CA222793-03 PA16-160 632341 2020
Kirchhoff, Tomas New York University School of Medicine The Identification of Genetic Determinants of Melanoma Recurrence 5R01CA187060-05 PA13-302 442152 2019
Kohlmann, Wendy K University of Utah Analysis of Brca Testing Patterns Using the Utah Population Database 5R03CA212911-02 PAR14-007 76250 2018
Kroenke, Candyce H Kaiser Foundation Research Institute Social Networks and Disparities in Health Behaviors and Breast Cancer Outcomes in Immigrant Women 5R01CA230440-02 PA17-041 645782 2020
Kroetz, Deanna L University of California, San Francisco Pharmacogenomics of Microtubule Targeting Agents 5R01CA192156-05 PA13-302 526471 2019
Krull, Kevin R St. Jude Children's Research Hospital Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (Apnea 5R01CA215405-03 PA16-160 585449 2019
Kurian, Allison W. Stanford University Genetic Testing, Treatment Use, and Mortality After Diagnosis of Breast and Ovarian Cancer: the Georgia-California Genelink Initiative 5R01CA225697-03 PA16-160 433498 2020
Kushi, Lawrence H Kaiser Foundation Research Institute Infrastructure for Pathways, a Prospective Study of Breast Cancer Survivorship 5U01CA195565-05 PAR15-104 1836691 2020
Kushi, Lawrence H Kaiser Foundation Research Institute Breast White Adipose Tissue Inflammation and Breast Cancer Outcomes 1R01CA241409-01A1 PA19-056 981204 2020
Kwan, Marilyn L Kaiser Foundation Research Institute Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors 5R01CA172855-05 PA11-260 926417 2018
Kwan, Marilyn L Kaiser Foundation Research Institute Predictors of Cvd Among Breast Cancer Survivors in an Integrated Health System 5R01CA214057-04 PA16-035 618653 2020
Lee, Donghoon Harvard School of Public Health Integrative Approach to Understand the Role of Diet, Physical Activity and Adiposity on Survival in Patients with Colorectal, Endometrial and Prostate Cancer 1R03CA249027-01 PAR18-021 97693 2020
Li, Christopher I Fred Hutchinson Cancer Research Center Discovery and Verification of Novel Biomarkers of Colorectal Cancer Recurrence 5R01CA189184-06 PA13-302 420049 2020
Li, Guojun University of TX MD Anderson Can Ctr Immuno-Inflammatory Response Non-Coding Rnas as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients 1R01CA236859-01A1 PA19-056 384978 2020
Malone, Kathleen E Fred Hutchinson Cancer Research Center Epidemiology of the Four Most Frequent Cancers Following Breast Cancer 5R01CA192438-05 PA13-302 928970 2018
Malone, Kathleen E Fred Hutchinson Cancer Research Center Molecular Pathoepidemiology of Contralateral Breast Cancer 5R01CA206464-04 PA13-302 2016169 2020
Mendoza, Tito R University of TX MD Anderson Can Ctr Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments That Include Immune Checkpoint Inhibitors and Targeted Therapy 5R01CA242565-02 PAR18-869 366000 2020
Nathanson, Katherine L. University of Pennsylvania Randomized Trial of Universal Vs. Guideline-Directed Germline Testing Among Young Adults with Cancer 1U01CA232836-01A1 CA19-017 4815109 2019
Newcomb, Polly A Fred Hutchinson Cancer Research Center Serrated Colorectal Cancer: an Emerging Disease Subtype 5R01CA196337-06 PA13-302 343891 2020
Nichols, Hazel B Univ of North Carolina Chapel Hill In Vitro Fertilization Outcomes After Cancer 1R01CA211093-01A1 PA18-484 497540 2019
Pal, Tuya Vanderbilt University Medical Center Breast Cancer in Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT) 5R01CA204819-04 PAR15-093 368599 2020
Park, Yikyung Washington University Dietary Patterns and Cardiovascular Disease Risk in Childhood Cancer Survivors: St. Jude Lifetime Cohort 1R03CA252485-01 PAR18-021 182771 2020
Penney, Kathryn L Brigham and Women's Hospital Comprehensive Characterization of Prostate Stromal Gene Expression and Association with Lethal Prostate Cancer 5R37CA227190-03 PA16-160 497668 2020
Peres, Lauren Cole H. Lee Moffitt Cancer Ctr & Res Inst The Role of Inflammation in the Racial Disparities in Ovarian Cancer Survival 5R00CA218681-03 PA16-193 228786 2019
Peters, Ulrike Fred Hutchinson Cancer Research Center Interdisciplinary Epidemiologic Consortium to Investigate T-Cell Response in Colorectal Cancer 1R01CA248857-01 PA19-056 768324 2020
Poisson, Laila M Henry Ford Health System Molecular and Clinical Evaluation of the Glioma Patient Experience to Anticipate Modern Outcomes and Guide Patient Care 5R01CA222146-02 PA16-160 591350 2019
Rahm, Alanna K Geisinger Clinic Assessing Non-Inferiority of Scalable Econsent for Genomics 3R01CA211723-03S1 PA19-217 162888 2019
Rahm, Alanna K Geisinger Clinic Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizational Contexts 5R01CA211723-03 PAR16-238 649351 2019
Reif, David M North Carolina State University Raleigh Genetic Etiology of Cancer Drug Response 5R01CA161608-08 PA16-160 479088 2020
Rohan, Thomas E Albert Einstein College of Medicine Tmem, Menacalc, and Menainv as Prognostic and Predictive Markers for Breast Cancer Metastasis 1R01CA240646-01A1 PA19-056 909583 2020
Schildkraut, Joellen M. Emory University Ovarian Cancer Survival in African-American Women 1R01CA237318-01A1 PA19-056 1378411 2020
Schwartz, Ann G. Wayne State University Detroit Research on Cancer Survivors (Detroit Rocs) 5U01CA199240-04 PAR15-104 1766046 2020
Skolarus, Ted Albert University of Michigan at Ann Arbor Refining Castration Use for Recurrent Prostate Cancer 1R01CA242559-01A1 PA19-056 343324 2020
Slager, Susan L. Mayo Clinic Rochester Integration of Germline and Tumor Genomes in Cll 5R01CA235026-02 PA18-484 639092 2020
Slansky, Jill E University of Colorado Denver T Cell Responses Shared Among Triple Negative Breast Cancer Patients 5R21CA230487-02 PA16-175 167411 2019
Su, Min-Ying L University of California-Irvine Mammographic Density and Metabolic Genotyping for Predicting Cancer Prognosis 5R21CA208938-02 PAR16-176 168019 2018
Syngal, Sapna Dana-Farber Cancer Inst Development and Validation of Clinical Prediction Models for the Use and Interpretation of Multigene Hereditary Cancer Risk Assessment 5R01CA132829-11 PA16-160 455443 2020
Syrjala, Karen Leslie Fred Hutchinson Cancer Research Center Integrating Health Informatics in a Scalable Stepped Care Self-Management Program for Survivors After Hematopoietic Cell Transplantation 5R01CA215134-04 PA16-160 723566 2020
Thomas, Nancy E Univ of North Carolina Chapel Hill Identification of Lethal Melanomas at the Time of Diagnosis 1R01CA233524-01A1 PA19-056 972565 2020
Tyekucheva, Svitlana Dana-Farber Cancer Inst Curated Prostate Cancer Data for Novel and Reproducible Prognostic Modeling 1R21CA241647-01A1 PA17-243 265599 2020
Ulrich, Cornelia M. University of Utah Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer Recurrence 5R01CA207371-03 PA16-160 555888 2020
Ulrich, Cornelia M. University of Utah Transdisciplinary Team Science in Colorectal Cancer Prognosis: the Colocare Study 5U01CA206110-04 PAR15-104 1717150 2019
Weaver, Kathryn Elizabeth Wake Forest University Health Sciences Assessing Efficacy and Implementation of an Ehr Tool to Assess Heart Health Among Survivors 5R01CA226078-02 PA16-035 517927 2020
Wesselmann, Ursula Isolde University of Alabama at Birmingham Life After Breast Cancer Treatment: Racial Health Disparities and Chronic Pain in Breast Cancer Survivors. 1R01CA246708-01 PAR18-869 323152 2020
West, Robert B Stanford University Genomic and Morphologic Predictor of High-Risk Dcis 5R01CA193694-05 PA13-302 692210 2020
Wiencke, John K. University of California, San Francisco Immune Epigenetic Biomarkers of Survival in Glioma Epidemiology 5R01CA207360-03 PA16-160 821594 2019
Wiesner, Georgia L Vanderbilt University Medical Center Improving Identification and Healthcare for Patients with Inherited Cancer Syndromes: Evidence-Based Emr Implementation Using a Web-Based Computer Platform 1U01CA232829-01A1 CA19-017 5339027 2019
Yao, Song Roswell Park Cancer Institute Corp Genetic Underpinnings of Ethnic Disparities in Bone Toxicities Between Hispanic and Non-Hispanic Children Treated for Acute Lymphoblastic Leukemia 5R03CA223730-02 PAR16-416 87050 2019
Yasui, Yutaka St. Jude Children's Research Hospital Late Effects Prediction Using Clinical Phenotypes and Whole Genome Sequencing 5R01CA216354-04 PAR16-218 628281 2020
Zhang, Jianjun University of TX MD Anderson Can Ctr The Molecular and Immune Evolution in the Progression of Lung Neoplasia to Invasive Adenocarcinoma 5R01CA234629-02 PA17-459 366000 2020